Acute paretic syndrome in juvenile White Leghorn chickens resembles late stages of acute inflammatory demyelinating polyneuropathies in humans

Journal of Neuroinflammation

Volumn 7, Issue , 2010, Pages

  Bader, Sophie R ^a   Kothlow, Sonja ^a   Trapp, Sascha ^a   Schwarz, Susanne C N ^a   Philipp, Hans Christian ^b   Weigend, Steffen ^c   Sharifi, Ahmad R ^d   Preisinger, Rudolf ^b   Schmahl, Wolfgang ^a   Kaspers, Bernd ^a   Matiasek, Kaspar ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LOHMANN TIERZUCHT GMBH   (Germany)

^c FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTININ; AGGLUTININ 1; IMMUNOGLOBULIN G; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 13; MAJOR HISTOCOMPATIBILITY ANTIGEN; MYELIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; LEUKOCYTE ANTIGEN; PLANT LECTIN; RICINUS COMMUNIS AGGLUTININ 1; RICINUS COMMUNIS AGGLUTININ-1; VIRUS ENVELOPE PROTEIN;

ACUTE INFLAMMATORY DEMYELINATING POLYNEUROPATHY; ACUTE PARETIC SYNDROME; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; BIRD DISEASE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CHICKEN; CONTROLLED STUDY; CRANIAL NERVE; DEMYELINATION; DISEASE COURSE; EXTRACELLULAR MATRIX; FACIAL NERVE; FASCICULATION; FEMALE; FLACCID PARALYSIS; FLOW CYTOMETRY; GENE EXPRESSION; GENE LOCUS; GENOTYPE; GUILLAIN BARRE SYNDROME; HELPER CELL; HUMORAL IMMUNITY; IMMUNOPATHOLOGY; LIMB WEAKNESS; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MARDIVIRUS; MICROGLIA; MUSCLE HYPERTONIA; NECK MUSCLE; NERVE FIBER; NERVE ROOT; NONHUMAN; OCULOMOTOR NERVE; PARESIS; PERIPHERAL NERVOUS SYSTEM; PHENOTYPE; PLASMA CELL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHWANN CELL; SPINAL NERVE; T LYMPHOCYTE SUBPOPULATION; TRANSMISSION ELECTRON MICROSCOPY; WHITE LEGHORN CHICKEN; ANIMAL; ANIMAL DISEASE; DISEASE MODEL; GENETICS; HUMAN; METABOLISM; METHODOLOGY; NEUROSYPHILIS; PATHOLOGY; PATHOPHYSIOLOGY; SPINAL CORD; SPINAL GANGLION; STATISTICAL MODEL; ULTRASTRUCTURE; VIROLOGY;

ANIMALS; ANTIGENS, CD; CHICKENS; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; GANGLIA, SPINAL; GENOTYPE; GUILLAIN-BARRE SYNDROME; HUMANS; LOGISTIC MODELS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROSCOPY, ELECTRON, TRANSMISSION; NEUROSYPHILIS; PLANT LECTINS; SPINAL CORD; SPINAL NERVES; VIRAL ENVELOPE PROTEINS;

EID: 77349089295     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-7-7     Document Type: Article

References (96)

1. Yu RK, Usuki S, Ariga T. Ganglioside molecular mimicry and its pathological roles in Guillain-Barre syndrome and related diseases. Infect Immun 2006, 74:6517-6527. 10.1128/IAI.00967-06, 1698092, 16966405.
2. Hughes RA, Hadden RD, Gregson NA, Smith KJ. Pathogenesis of Guillain-Barre syndrome. J Neuroimmunol 1999, 100:74-97. 10.1016/S0165-5728(99)00195-2, 10695718.
3. Latov N. Diagnosis of CIDP. Neurology 2002, 59:S2-6.
4. McCombe PA, Pollard JD, McLeod JG. Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain 1987, 110(Pt 6):1617-1630. 10.1093/brain/110.6.1617, 3427403.
5. Hadden RD, Hughes RA. Management of inflammatory neuropathies. J Neurol Neurosurg Psychiatry 2003, 74(Suppl 2):ii9-ii14. 1765628, 12754323.
6. Csurhes PA, Sullivan AA, Green K, Pender MP, McCombe PA. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 2005, 76:1431-1439. 10.1136/jnnp.2004.052282, 1739377, 16170091.
7. Shu XM, Cai FC, Zhang XP. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy. Muscle Nerve 2006, 33:225-231. 10.1002/mus.20457, 16270308.
8. Nachamkin I, Ung H, Moran AP, Yoo D, Prendergast MM, Nicholson MA, Sheikh K, Ho T, Asbury AK, McKhann GM, Griffin JW. Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States. J Infect Dis 1999, 179:1183-1189. 10.1086/314725, 10191221.
9. Ekerfelt C, Dahle C, Weissert R, Kvarnstrom M, Olsson T, Ernerudh J. Transfer of myelin-specific cells deviated in vitro towards IL-4 production ameliorates ongoing experimental allergic neuritis. Clin Exp Immunol 2001, 123:112-118. 10.1046/j.1365-2249.2001.01424.x, 1905957, 11168007.
10. Dahle C, Ekerfelt C, Vrethem M, Samuelsson M, Ernerudh J. T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain-Barre syndrome. J Neurol Sci 1997, 153:54-60. 10.1016/S0022-510X(97)00178-0, 9455979.
11. Linington C, Izumo S, Suzuki M, Uyemura K, Meyermann R, Wekerle H. A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo. J Immunol 1984, 133:1946-1950.
12. Gold R, Hartung HP, Toyka KV. Animal models for autoimmune demyelinating disorders of the nervous system. Mol Med Today 2000, 6:88-91. 10.1016/S1357-4310(99)01639-1, 10652482.
13. Maurer M, Toyka KV, Gold R. Immune mechanisms in acquired demyelinating neuropathies: lessons from animal models. Neuromuscul Disord 2002, 12:405-414. 10.1016/S0960-8966(01)00302-9, 12062260.
14. Hahn AF. Experimental allergic neuritis (EAN) as a model for the immune-mediated demyelinating neuropathies. Rev Neurol (Paris) 1996, 152:328-332.
15. Braund KG, Vallat JM, Steiss JE, Panangala VS, Zimmer PL. Chronic inflammatory demyelinating polyneuropathy in dogs and cats. J Peripher Nerv Syst 1996, 1:149-155.
16. Bacon LD, Witter RL, Silva RF. Characterisation and experimental reproduction of peripheral neuropathy in White Leghorn chickens. Avian Pathology 2001, 30:487-499. 10.1080/03079450120078680, 19184938.
17. Clippinger TL, Bennett RA, Platt SR. The avian neurologic examination and ancillary neurodiagnostic techniques: a review update. Vet Clin North Am Exot Anim Pract 2007, 10:803-836. 10.1016/j.cvex.2007.04.006, 17765849.
18. Erhardt W, Henke J, Haberstroh J. Anästhesie und Analgesie beim Klein- und Heimtier: Sowie bei Vögeln, Reptilien, Amphibien und Fischen. Schattauer 2004,
19. Dyck PJ, Chalk CH. The 10 P's: a mnemonic helpful in characterization and differential diagnosis of peripheral neuropathy. Neurology 1992, 42:14-18.
20. Maier H, Schmidbauer M, Pfausler B, Schmutzhard E, Budka H. Central nervous system pathology in patients with the Guillain-Barre syndrome. Brain 1997, 120(Pt 3):451-464. 10.1093/brain/120.3.451, 9126057.
21. Krinke GJ, Vidotto N, Weber E. Teased-fiber technique for peripheral myelinated nerves: methodology and interpretation. Toxicol Pathol 2000, 28:113-121. 10.1177/019262330002800114, 10668997.
22. Mizisin AP, Nelson RW, Sturges BK, Vernau KM, Lecouteur RA, Williams DC, Burgers ML, Shelton GD. Comparable myelinated nerve pathology in feline and human diabetes mellitus. Acta Neuropathol 2007, 113:431-442. 10.1007/s00401-006-0163-8, 17237938.
23. Midroni GYL, Bilbao JM. Biopsy diagnosis of peripheral neuropathy 1995, Toronto: Butterworth-Heinemann.
24. Ochoa J. Recognition of unmyelinated fiber disease: morphologic criteria. Muscle Nerve 1978, 1:375-387. 10.1002/mus.880010506, 233736.
25. Rothwell CJ, Vervelde L, Davison TF. Identification of chicken Bu-1 alloantigens using the monoclonal antibody AV20. Vet Immunol Immunopathol 1996, 55:225-234. 10.1016/S0165-2427(96)05635-8, 9014319.
26. Chen CL, Ager LL, Gartland GL, Cooper MD. Identification of a T3/T cell receptor complex in chickens. J Exp Med 1986, 164:375-380. 10.1084/jem.164.1.375, 2188201, 2425031.
27. Luhtala M, Salomonsen J, Hirota Y, Onodera T, Toivanen P, Vainio O. Analysis of chicken CD4 by monoclonal antibodies indicates evolutionary conservation between avian and mammalian species. Hybridoma 1993, 12:633-646. 10.1089/hyb.1993.12.633, 7507081.
28. Luhtala M, Koskinen R, Toivanen P, Vainio O. Characterization of chicken CD8-specific monoclonal antibodies recognizing novel epitopes. Scand J Immunol 1995, 42:171-174. 10.1111/j.1365-3083.1995.tb03641.x, 7543213.
29. Sowder JT, Chen CL, Ager LL, Chan MM, Cooper MD. A large subpopulation of avian T cells express a homologue of the mammalian T gamma/delta receptor. J Exp Med 1988, 167:315-322. 10.1084/jem.167.2.315, 2188863, 3258004.
30. Cihak J, Ziegler-Heitbrock HW, Trainer H, Schranner I, Merkenschlager M, Losch U. Characterization and functional properties of a novel monoclonal antibody which identifies a T cell receptor in chickens. Eur J Immunol 1988, 18:533-537. 10.1002/eji.1830180407, 3259182.
31. Chen CH, Sowder JT, Lahti JM, Cihak J, Losch U, Cooper MD. TCR3: a third T-cell receptor in the chicken. Proc Natl Acad Sci USA 1989, 86:2351-2355. 10.1073/pnas.86.7.2351, 286910, 2648400.
32. Char D, Sanchez P, Chen CL, Bucy RP, Cooper MD. A third sublineage of avian T cells can be identified with a T cell receptor-3-specific antibody. J Immunol 1990, 145:3547-3555.
33. Mast J, Goddeeris BM, Peeters K, Vandesande F, Berghman LR. Characterisation of chicken monocytes, macrophages and interdigitating cells by the monoclonal antibody KUL01. Vet Immunol Immunopathol 1998, 61:343-357. 10.1016/S0165-2427(97)00152-9, 9613446.
34. Erhard MH, Von Quistorp I, Schranner I, Jungling A, Kaspers B, Schmidt P, Kuhlmann R. Development of specific enzyme-linked immunosorbent antibody assay systems for the detection of chicken immunoglobulins G, M, and A using monoclonal antibodies. Poult Sci 1992, 71:302-310.
35. Pavlakis K, Messini I, Athanassiadou S, Kyrodimou E, Pandazopoulou A, Vrekoussis T, Stathopoulos EN. Endocervical glandular lesions: a diagnostic approach combining a semi-quantitative scoring method to the expression of CEA, MIB-1 and p16. Gynecol Oncol 2006, 103:971-976. 10.1016/j.ygyno.2006.06.012, 16876235.
36. Shin DH, Lee E, Cho SS. Glial cells in the chicken optic tectum. Brain Res 2003, 962:221-225. 10.1016/S0006-8993(02)03889-1, 12543473.
37. Watson JV. Introduction to flow cytometry 2004, Cambridge University Press.
38. Tregaskes CA, Bumstead N, Davison TF, Young JR. Chicken B-cell marker chB6 (Bu-1) is a highly glycosylated protein of unique structure. Immunogenetics 1996, 44:212-217. 10.1007/BF02602587, 8662088.
39. Veromaa T, Vainio O, Eerola E, Toivanen P. Monoclonal antibodies against chicken Bu-1a and Bu-1b alloantigens. Hybridoma 1988, 7:41-48. 10.1089/hyb.1988.7.41, 2453446.
40. Fulton JE, Juul-Madsen HR, Ashwell CM, McCarron AM, Arthur JA, O'Sullivan NP, Taylor RL. Molecular genotype identification of the Gallus gallus major histocompatibility complex. Immunogenetics 2006, 58:407-421. 10.1007/s00251-006-0119-0, 16738938.
41. Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual 2001, Ney York, USA.: Cold Spring Harbor Laboratory Press, 3.
42. Spatz SJ, Silva RF. Sequence determination of variable regions within the genomes of Gallid herpesvirus-2 pathotypes. Archives of Virology 2007, 152:1665-1678. 10.1007/s00705-007-0992-3, 17557133.
43. Akiyama Y, Kato S. Two cell lines from lymphomas of Marek's disease. Biken J 1974, 17:105-116.
44. Sharma JM. Lack of a threshold of genetic resistance to marek's disease and the incidence of humoral antibody. AVian Pathology 1973, 2:275-290.
45. Doi K, Kojima A, Naito M, Kato S. Histopathological changes occasionally found in the peripheral nerve of chickens free from Marek's disease. Natl Inst Anim Health Q (Tokyo) 1973, 13:227-228.
46. Schwerer B. Antibodies against gangliosides: a link between preceding infection and immunopathogenesis of Guillain-Barre syndrome. Microbes Infect 2002, 4:373-384. 10.1016/S1286-4579(02)01550-2, 11909748.
47. Hafer-Macko CE, Sheikh KA, Li CY, Ho TW, Cornblath DR, McKhann GM, Asbury AK, Griffin JW. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 1996, 39:625-635. 10.1002/ana.410390512, 8619548.
48. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002, 125:2591-2625. 10.1093/brain/awf272, 12429589.
49. Bradley LM, Dalton DK, Croft M. A direct role for IFN-gamma in regulation of Th1 cell development. J Immunol 1996, 157:1350-1358.
50. McKenzie GJ, Bancroft A, Grencis RK, McKenzie AN. A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr Biol 1998, 8:339-342. 10.1016/S0960-9822(98)70134-4, 9512421.
51. Jander S, Stoll G. Interleukin-18 is induced in acute inflammatory demyelinating polyneuropathy. J Neuroimmunol 2001, 114:253-258. 10.1016/S0165-5728(00)00460-4, 11240039.
52. Zhu J, Link H, Mix E, Olsson T, Huang WX. Th1-like cell responses to peripheral nerve myelin components over the course of experimental allergic neuritis in Lewis rats. Acta Neurol Scand 1994, 90:19-25.
53. Koski CL, Chou DK, Jungalwala FB. Anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen. J Clin Invest 1989, 84:280-287. 10.1172/JCI114152, 303980, 2738153.
54. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989, 170:2081-2095. 10.1084/jem.170.6.2081, 2189521, 2531194.
55. Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A, Giltnane JM, Yang L, Zhao H, Calame K, Staudt LM. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 2002, 17:51-62. 10.1016/S1074-7613(02)00335-7, 12150891.
56. Cocks BG, de Waal Malefyt R, Galizzi JP, de Vries JE, Aversa G. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int Immunol 1993, 5:657-663. 10.1093/intimm/5.6.657, 7688562.
57. Defrance T, Carayon P, Billian G, Guillemot JC, Minty A, Caput D, Ferrara P. Interleukin 13 is a B cell stimulating factor. J Exp Med 1994, 179:135-143. 10.1084/jem.179.1.135, 2191343, 7903680.
58. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991, 174:1209-1220. 10.1084/jem.174.5.1209, 2119001, 1940799.
59. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991, 146:3444-3451.
60. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990, 265:621-636. 1133681, 1689567.
61. Prowse KR, Baumann H. Interleukin-1 and interleukin-6 stimulate acute-phase protein production in primary mouse hepatocytes. J Leukoc Biol 1989, 45:55-61.
62. Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983, 158:670-689. 10.1084/jem.158.3.670, 2187114, 6411853.
63. Teng X, Zhang H, Snead C, Catravas JD. Molecular mechanisms of iNOS induction by IL-1 beta and IFN-gamma in rat aortic smooth muscle cells. Am J Physiol Cell Physiol 2002, 282:C144-152.
64. Inglis HR, Csurhes PA, McCombe PA. Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy. J Neurol Neurosurg Psychiatry 2007, 78:419-422. 10.1136/jnnp.2006.106617, 17158557.
65. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res 1997, 745:32-36. 10.1016/S0006-8993(96)01123-7, 9037391.
66. Yoshino H, Harukawa H, Asano A. IgG antiganglioside antibodies in Guillain-Barre syndrome with bulbar palsy. J Neuroimmunol 2000, 105:195-201. 10.1016/S0165-5728(99)00280-5, 10742563.
67. Kaida K, Ariga T, Yu RK. Antiganglioside antibodies and their pathophysiological effects on Guillain-Barre syndrome and related disorders--a review. Glycobiology 2009, 19:676-692. 10.1093/glycob/cwp027, 19240270.
68. Willison HJ. Ganglioside complexes as targets for antibodies in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 2006, 77:1002-1003. 10.1136/jnnp.2006.094441, 2077746, 16754692.
69. Fross RD, Daube JR. Neuropathy in the Miller Fisher syndrome: clinical and electrophysiologic findings. Neurology 1987, 37:1493-1498.
70. Hadden RD, Gregson NA. Guillain--Barre syndrome and Campylobacter jejuni infection. Symp Ser Soc Appl Microbiol 2001, 145S-154S.
71. Winer J, Hughes S, Cooper J, Ben-Smith A, Savage C. Gamma delta T cells infiltrating sensory nerve biopsies from patients with inflammatory neuropathy. J Neurol 2002, 249:616-621. 10.1007/s004150200072, 12021953.
72. Allison TJ, Garboczi DN. Structure of gammadelta T cell receptors and their recognition of non-peptide antigens. Mol Immunol 2002, 38:1051-1061. 10.1016/S0161-5890(02)00034-2, 11955597.
73. Bridle BW, Julian R, Shewen PE, Vaillancourt JP, Kaushik AK. T lymphocyte subpopulations diverge in commercially raised chickens. Can J Vet Res 2006, 70:183-190. 1477934, 16850940.
74. Robak E, Niewiadomska H, Robak T, Bartkowiak J, Blonski JZ, Wozniacka A, Pomorski L, Sysa-Jedrezejowska A. Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity. Mediators Inflamm 2001, 10:179-189. 10.1080/09629350120080300, 1781712, 11577994.
75. Arnason BGW. Inflammatory polyradiculoneuropathies 1975, Philadelphia: W. B. Sanders.
76. Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, Schubert J, Weishaupt A, Cornblath DR, Swan AV, Hughes RA, Toyka KV. Preceding infections, immune factors, and outcome in Guillain-Barre syndrome. Neurology 2001, 56:758-765.
77. Souayah N, Nasar A, Suri MF, Qureshi AI. Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System. Vaccine 2007, 25:5253-5255. 10.1016/j.vaccine.2007.03.053, 17560693.
78. Osterrieder N, Kamil JP, Schumacher D, Tischer BK, Trapp S. Marek's disease virus: from miasma to model. Nat Rev Microbiol 2006, 4:283-294. 10.1038/nrmicro1382, 16541136.
79. Lampert P, Garrett R, Powell H. Demyelination in Allergic and Marek's Disease Virus Induced Neuritis Comparative Electron Microscopy Studies. Acta Neuropathologica 1977, 40:103-110. 10.1007/BF00688697, 201143.
80. Pepose JS. A theory of virus-induced demyelination in the Landry-Guillain-Barre syndrome. J Neurol 1982, 227:93-97. 10.1007/BF00313775, 6180144.
81. Pepose JS, Stevens JG, Cook ML, Lampert PW. Marek's disease as a model for the Landry--Guillain--Barre syndrome: latent viral infection in nonneuronal cells accompanied by specific immune responses to peripheral nerve and myelin. Am J Pathol 1981, 103:309-320. 1903836, 7234967.
82. Pavone P, Maccarrone F, Sorge A, Piccolo G, Greco F, Caruso P, Sorge G. Guillain-Barre syndrome after varicella zoster virus infections. A case report. Minerva Pediatr 2002, 54:259-262.
83. Roccatagliata L, Uccelli A, Murialdo A. Guillain-Barre syndrome after reactivation of varicella-zoster virus. N Engl J Med 2001, 344:65-66. 10.1056/NEJM200101043440117, 11187118.
84. Jacobs BC, Rothbarth PH, Meche FG, Herbrink P, Schmitz PI, de Klerk MA, van Doorn PA. The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study. Neurology 1998, 51:1110-1115.
85. Dowling PC, Cook SD. Role of infection in Guillain-Barre syndrome: laboratory confirmation of herpesviruses in 41 cases. Ann Neurol 1981, 9(Suppl):44-55. 10.1002/ana.410090709, 6261680.
86. Dowling PC, Bosch VV, Cook SD, Chmel H. Serum immunoglobulins in Guillain-Barre syndrome. J Neurol Sci 1982, 57:435-440. 10.1016/0022-510X(82)90047-8, 7161628.
87. (CDC) CfDCaP Update: Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June 2005-September 2006. MMWR Morb Mortal Wkly Rep 2006, 55:1120-1124. (CDC) CfDCaP.
88. Siddiqui A, Usmani RI, Anwer S, Afsar S. Guillain-Barre syndrome occurring after rabies vaccination. J Pak Med Assoc 2005, 55:87-88.
89. Schattner A. Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 2005, 23:3876-3886. 10.1016/j.vaccine.2005.03.005, 15917108.
90. Roth MP, Viratelle C, Dolbois L, Delverdier M, Borot N, Pelletier L, Druet P, Clanet M, Coppin H. A genome-wide search identifies two susceptibility loci for experimental autoimmune encephalomyelitis on rat chromosomes 4 and 10. J Immunol 1999, 162:1917-1922.
91. McCombe PA, Csurhes PA, Greer JM. Studies of HLA associations in male and female patients with Guillain-Barre syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). J Neuroimmunol 2006, 180:172-177. 10.1016/j.jneuroim.2006.07.017, 16935351.
92. Geleijns K, Brouwer BA, Jacobs BC, Houwing-Duistermaat JJ, van Duijn CM, van Doorn PA. The occurrence of Guillain-Barre syndrome within families. Neurology 2004, 63:1747-1750.
93. van Sorge NM, Pol WL, Jansen MD, Geleijns KP, Kalmijn S, Hughes RA, Rees JH, Pritchard J, Vedeler CA, Myhr KM, et al. Severity of Guillain-Barre syndrome is associated with Fc gamma Receptor III polymorphisms. J Neuroimmunol 2005, 162:157-164. 10.1016/j.jneuroim.2005.01.016, 15833371.
94. Muller HD, Beckmann A, Schroder JM. Inflammatory infiltrates in the spinal cord of patients with Guillain-Barre syndrome. Acta Neuropathol 2003, 106:509-517. 10.1007/s00401-003-0768-0, 13680278.
95. Hughes RA, Cornblath DR. Guillain-Barre syndrome. Lancet 2005, 366:1653-1666. 10.1016/S0140-6736(05)67665-9, 16271648.
96. International Chicken Genome Sequencing Consortium Sequence and comparative analysis of the chicken genome provide unique perspectives on vertebrate evolution. Nature 2004, 432:695-716. 10.1038/nature03154, 15592404, International Chicken Genome Sequencing Consortium.